Navigation Links
‘Delayed Reaction’ to Radiation Therapy Takes the Life of a Woman After 30 Yeas

An inquiry into the death of Patricia Rooper, who died following a 'delayed reaction' to the radiation treatment she received// more than 30 years ago, has revealed that radiation had caused her death last year at 69 years of age.

Mrs. Rooper was diagnosed with cancer of the left breast in 1971 when she was 34. After a mastectomy, she was also subjected to intensive radiotherapy at Hammersmith hospital in London. There she received 20 installments of radiotherapy spread over four weeks.

In 1972, Patricia Rooper was completely cleared from the disease following a month of radiotherapy. But the treatment had left her debilitated with a host of health problems that plagued her in the following years.

Mrs. Roper, suffered unrelenting cough, fractured ribs and scarring in the chest. Her left had become semi-paralyzed. Last year she died following a hemorrhage.

During the investigation following her death, doctors noticed scar tissue covered over her chest, due to which her internal organs were compressed. This led to lack of blood supply in certain parts of her body.

Coroner Peter Bedford during the investigation hearing ruled that Mrs. Roper died as a result of a delayed reaction to radiotherapy. He said: 'One is almost shocked to hear that somebody should endure such a treatment when it is designed to help them overcome a disease. But I must bear in mind that the way in which radiotherapy was approached has now been refined. In 1971 the world was a different place and doctors felt that the important thing was to zap the cancer without much thought for the consequences for the patient afterwards.'

According to Mr. Jean McFarlane, who belongs to the Radiotherapy Action Group Exposure, the Government will certainly pay compensation for victims when radiation treatment is officially recognized as the cause of death.

Michael Williams, Vice President of Royal College of Radiologists, said: '
'"/>




Page: 1 2

Related medicine news :

1. Radiation before surgery cuts cancer recurrence
2. UV Radiation induces Melanoma
3. Radiation reduces cancer recurrence
4. Radiation before surgery cuts cancer reappearance
5. Radiation Not Needed for Childhood Cancers
6. Does Radiation Cause Lung Cancer?
7. Radiation for Bone Pain
8. Radiation for Bone Pain
9. Radiation after Breast Reconstruction
10. Radiation Exposure Found To Affect Intellect Later In Life
11. Radiation Therapy An Effective Solution For Recurrent Prostate Cancer

Post Your Comments:
(Date:11/7/2009)...id A. Cook (GA), Louis J. Goodman (TX), Palmer P. ...ICAGO, Nov. 7 The Ameri... medical society executive leaders with achievemen... and ideals of the medical profession. The awards ...ing meeting in Houston. ,, (Logo: http://www...
(Date:11/7/2009)...USNewswire/ -- The U.S. bishops November 7 urged m... the Stupak-Ellsworth Amendment to the health care...Dahlkemper-Lipinski-Smith Amendment will keep in p...onscience protections in the Affordable Health Car...he letter was signed by Cardinal Justin Rigali, ch...
(Date:11/7/2009)...roblem across the U.S. , , SATURDAY, Nov. ...our-year colleges do it regularly (and, it,s not s... or more alcoholic drinks at a sitting. , "People ...aid Jenny Hwang, associate dean of students and di...versity on Long Island, N.Y. In fact, she said, he...
(Date:11/6/2009)..., Nov. 6 /PRNewswire-FirstCall/ - Cardiome Pharma ...that it will report financial results for the thir...of Monday, November 9, 2009. Cardiome will hold a ...(6:00am Pacific) on that day to discuss the result...16-695-7806 or 888-789-9572 and reference conferen...
(Date:11/6/2009)...n (NYSE: CNC ) today announced that it will prese... next few weeks. ,, Next week, at the Credit Suiss...ovember 11-13, 2009, at the Arizona Biltmore Resor...ay, November 11th at 4:30 p.m. Mountain Time. Inve...ene,s presentation at: http://w.on24.com/r.htm?e...
Breaking Medicine News(10 mins):Health News:AMA Honors Medical Society Executives 2Health News:Bishops Urge Passage of Stupak-Ellsworth Anti-Abortion Amendment for Health Reform Bill 2Health News:Binge Drinking Puts the Brain, and Life Itself, at Risk 2Health News:Binge Drinking Puts the Brain, and Life Itself, at Risk 3Health News:Cardiome to Release Third Quarter Results 2Health News:Cardiome to Release Third Quarter Results 3Health News:Centene Corporation to Present at Upcoming Healthcare Conferences 2
...ony Ohotto, a physician,with Signature Hospice, ha...ttoo. "Limited life expectancy is no reason not to...e wrote the order as a health clearance, a,stateme... emotional decline in their young patient with a n...
...Long-Time Twin Cities Health Care ...rk G. Mishek, a Minnesota native,with extensive ex... Monday,as President and CEO of Hazelden, the nati...o: http://www.newscom.com/cgi-bin/prnh/20080825/A...
...ecting the expanding,scope of chronic disease care...environmental factors on health care systems and p...blisher Mary Ann Liebert Inc. have renamed,the pee... (Volume 11, Number 4). With the new name comes a,...
...n with certain genotype more affected, study finds...reast-feeding moms who take medicines containing c...eir infant, new Canadian research suggests. , The ... -- possibly harming the infant,s central nervous ...
...ases the risk of developing cancers of the respira...ysis, which the authors say is the first prospecti...rs in the October 1, 2008 issue of CANCER, a pee...rning incensewhich is made of plant materials mixe...
...enefit Group, LLC announces iCan Insurance, LLC (&...w offering major medical health plans from Avalon ...aton, FL (PRWEB) August 24, 2008 -- iCan Benefit G...re, Inc. http://www.icanbenefit.com/majorMedical/...
Other Medicine News:Health News:Signature Hospice Team Grants Patient's Unusual Wish 2Health News:Mark G. Mishek Is New President and CEO of Hazelden 2Health News:Disease Management Journal Changes Name and Expands Focus to Population Health Management 2Health News:Taking Codeine While Breast-Feeding May Harm Infant 2Health News:Taking Codeine While Breast-Feeding May Harm Infant 3Health News:Burning incense increases risk of respiratory tract cancers 2Health News:iCan Benefit Group, LLC Announces: Major Medical Division Now Offers Avalon Healthcare Products 2
(Date:11/6/2009)...anitoba, Nov. 6 With his proposed ...s set his sights on cutting name-brand prescriptio...ho fall into the "Part D" coverage gap, universall...bout the potential cost-cutting and feel it,s a pr...he most powerful lobbyists want a revised program ...
(Date:11/6/2009)...IANGLE PARK, N.C., Nov. 6 Chimerix...ly-available antiviral therapeutics to address lif...evelopment of the company,s lead antiviral compoun...and the Global Health Security Initiative (GHSI). ...developed for the treatment of smallpox, as well a...
(Date:11/6/2009)...Nov. 6 NexBio Inc., in collaborati...rol and Prevention (CDC), St. Louis University, an... publication of two articles in the peer-reviewed ...gest that DAS181 (Fludase ® ) may play a pote...ntion of the Pandemic Influenza A(H1N1) and drug-r...
Breaking Medicine Technology:Obama Healthcare Reforms Fall Short, but Betterthanmedicare.com Closes the 'Donut Hole' 2Obama Healthcare Reforms Fall Short, but Betterthanmedicare.com Closes the 'Donut Hole' 3Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 2Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 3NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 2NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 3NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 4Michael J Fox Foundation Awards 243 8 Million To Drive Nine Industry Partnerships For Pre Clinical Parkinsons Drug Development 52311 1Michael J Fox Foundation Awards 243 8 Million To Drive Nine Industry Partnerships For Pre Clinical Parkinsons Drug Development 52311 2Michael J Fox Foundation Awards 243 8 Million To Drive Nine Industry Partnerships For Pre Clinical Parkinsons Drug Development 52311 3Studies Show Genetic Activity of Antioxidants 52308 1Studies Show Genetic Activity of Antioxidants 52308 2Studies Show Genetic Activity of Antioxidants 52308 3Winners of the C Everett Koop Health Project Award Announced 52305 1Winners of the C Everett Koop Health Project Award Announced 52305 2
...ging Results for a Potential New Front-Line Treatm...AMBRIDGE, Mass., June 2 Genzyme Corp.,(Nasdaq: G...-enrolled,pivotal, phase 2 study examining the saf...s a single agent in previously untreated, older ad... who are unlikely to benefit,from conventional "7+...
...esponse Trends Suggest Improved Efficacy with High... - Dose Escalation Ongoing -, SAN ...sdaq: MDVN ) today announced that data from an on...vel androgen receptor antagonist,MDV3100, showed e...ining,serum levels of prostate specific antigen (P...
Other Medicine Technology:Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 2Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 3Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 4Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 5Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 6Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 7Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 8Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration-Resistant Prostate Cancer Patients at 44th ASCO Annual Meeting 2Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration-Resistant Prostate Cancer Patients at 44th ASCO Annual Meeting 3Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration-Resistant Prostate Cancer Patients at 44th ASCO Annual Meeting 4
Liquichek Autoimmune Controls - Anti-Sm
VARIANTnbs Newborn Hemoglobin Screening System
...ring GmbH, the leading developer of laser diagnost...roduction of the Heidelberg Retina Tomograph 3 (HR...uct for the assessment, diagnosis and management o...ses laser technology to produce a topographical im...
Visante OCT Anterior Segment Imaging and Biometry
Medicine Products: